CTRL Therapeutics Inc

CTRL Therapeutics Inc. operates as a biotechnology company. The Company develops a next-generation cell therapy platform for the identification, isolation of circulating tumor-reactive lymphocytes, and enable the rapid generation of anti-tumor T cell repertoires from every patient with cancer. CTRL Therapeutics serves clients in the United States.